Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype

NCT: NCT05742360 · ACTIVE_NOT_RECRUITING

NCT IDNCT05742360
StatusACTIVE_NOT_RECRUITING
Start Date2023-02-07
Completion2028-03-01
SponsorOhio State University (OTHER)
First posted
Last updated

Brief Summary

The primary objective of this study is to determine the longer-term (6 months) effect of CPAP therapy on change in 24-hour mean blood pressure (24hMBP) in OSA subjects with the excessively sleepy symptom subtype.

Frequently Asked Questions

What is Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype?

Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype is a clinical trial registered under NCT05742360. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05742360?

The current status of NCT05742360 (Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype) is: ACTIVE_NOT_RECRUITING.

When did Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype start?

Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype started on 2023-02-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑